Clinical cardiovascular impact of valvular heart disease subtypes in chronic hemodialysis patients

Valvular heart disease (VHD) is highly prevalent in patients with end-stage kidney disease (ESKD) undergoing hemodialysis (HD), and is linked to adverse cardiovascular outcomes. However, data remain limited regarding its prognosis impact across different types of VHD in the population. We conducted a retrospective cohort study of 238 chronic HD patients with echocardiographic assessments at a single medical center. VHD was identified and classified by lesion types and number of affected valves (isolated vs. multivalvular). Clinical outcomes included all-cause mortality, major adverse cardiovascular events (MACE), and cardiovascular mortality. Cox proportional hazards models and Kaplan-Meier analyses were used for analysis. VHD was present in 87.4% of the cohort, with mitral regurgitation (MR) being the most common (91.3%), followed by aortic regurgitation (48.6%), aortic stenosis (13.0%), and mitral stenosis (1.4%). VHD patients were older and had higher coronary artery disease prevalence. Although VHD presence was not significantly associated with adverse outcomes in multivariable models, Kaplan-Meier analysis showed higher event trends (MACE: 38% vs. 20%; CV mortality: 18.3% vs. 6.7%). Subgroup analysis revealed that aortic stenosis (AS) was significantly associated with increased MACE risk (adjusted HR: 1.919; 95% CI: 1.065–3.548), and exploratory analyses suggested MR might be associated with all-cause mortality (adjusted HR: 2.538; 95% CI: 1.000–6.446). While overall VHD presence was not independently predictive of adverse outcomes, exploratory analyses identified potential associations between specific valvular lesions, such as AS and MR, and adverse clinical outcomes, emphasizing the need for further VHD subtype evaluation and risk stratification in chronic HD population.

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12882-026-05507-7
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical cardiovascular impact of valvular heart disease subtypes in chronic hemodialysis patients

Wan‐Lun Hsu, Chung‐Kuan Wu, Vy-Khanh Nguyen, Yukiko Ono
2 links
BMC Nephrology
Cardiac Valve Diseases and Treatments
article

Clinical cardiovascular impact of valvular heart disease subtypes in chronic hemodialysis patients

Wan‐Lun Hsu, Chung‐Kuan Wu, Vy-Khanh Nguyen, Yukiko Ono
article en

Abstract

Valvular heart disease (VHD) is highly prevalent in patients with end-stage kidney disease (ESKD) undergoing hemodialysis (HD), and is linked to adverse cardiovascular outcomes. However, data remain limited regarding its prognosis impact across different types of VHD in the population. We conducted a retrospective cohort study of 238 chronic HD patients with echocardiographic assessments at a single medical center. VHD was identified and classified by lesion types and number of affected valves (isolated vs. multivalvular). Clinical outcomes included all-cause mortality, major adverse cardiovascular events (MACE), and cardiovascular mortality. Cox proportional hazards models and Kaplan-Meier analyses were used for analysis. VHD was present in 87.4% of the cohort, with mitral regurgitation (MR) being the most common (91.3%), followed by aortic regurgitation (48.6%), aortic stenosis (13.0%), and mitral stenosis (1.4%). VHD patients were older and had higher coronary artery disease prevalence. Although VHD presence was not significantly associated with adverse outcomes in multivariable models, Kaplan-Meier analysis showed higher event trends (MACE: 38% vs. 20%; CV mortality: 18.3% vs. 6.7%). Subgroup analysis revealed that aortic stenosis (AS) was significantly associated with increased MACE risk (adjusted HR: 1.919; 95% CI: 1.065–3.548), and exploratory analyses suggested MR might be associated with all-cause mortality (adjusted HR: 2.538; 95% CI: 1.000–6.446). While overall VHD presence was not independently predictive of adverse outcomes, exploratory analyses identified potential associations between specific valvular lesions, such as AS and MR, and adverse clinical outcomes, emphasizing the need for further VHD subtype evaluation and risk stratification in chronic HD population.

BMC Nephrology
Fu Jen Catholic University (TW), Shin Kong WHS Memorial Hospital (TW), Taipei Medical University (TW)
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon